Blood tests are the gold standard for predicting disease progression. Unfortunately, blood tests may also be time consuming, expensive, and painful. What if your smartwatch could tell you when vital blood biomarkers change?
GPx is enhancing remote patient management by building a new class of biomarkers called Bloodless Blood Tests. Through our AI-powered Canary Prediction Engine, digital biomarkers collected from patient wearables and peripherals transform into an unparalleled window into patient blood biomarker status. With this data, physicians benefit from presymptomatic detection of critical patient condition changes, enabling timely treatment that avoids hospital readmissions.
HRX PREVIEW: Meet @GPx_Boston, a finalist for the #HRX2022 Pitch Competition! #HRStv host @jczerpa chats with Javier Echenique. Learn more about their unique technology, and why they’re ready for HRX. See more here #EPeeps ➡️ http://bit.ly/3TuNCYX